About Violet Therapeutics
Violet Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2021 in Delaware. It has reported $7,449,960 raised in one offering on Form D since May 2023. Its chief executive is Meredith Fisher.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 20, 2023 | May 5, 2023 | $7,449,960of $11.4M target | 4 | $1.8M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Violet Therapeutics's Form D filed May 5, 2023.
WY
William Yelle
Executive officer and director
AU
Atsushi Usami
Director
MF
Meredith Fisher
Chief Executive Officer and director
JB
Jonathan Behr
Director